Loading...

CM Life Sciences, Inc.

CMLFU•NASDAQ
Financial Services
Shell Companies
$13.00
$-0.62(-4.55%)

CM Life Sciences, Inc. (CMLFU) Stock Overview

Explore CM Life Sciences, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B

Score: 68.4/100

Key Financials

Market Cap10.3B
P/E Ratio-84.64
EPS (TTM)$-0.01
ROE0.00%
Fundamental Analysis

AI Price Forecasts

1 WeekN/A
1 MonthN/A
3 MonthsN/A
1 Year Target$11.60

CMLFU Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of CM Life Sciences, Inc. (CMLFU) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $11.60.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -84.64 and a market capitalization of 10.3B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for CMLFUStats details for CMLFU are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for CMLFUAnalyst Recommendations details for CMLFU are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

CM Life Sciences, Inc. intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. The company was founded in 2020 and is based in New York, New York.

CEO

Eli Decatur Casdin

Headquarters

667 Madison Avenue, New York City, NY

Founded

2020

Frequently Asked Questions

;